Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Feb-24 6:00 AM View:  | MannKind Corp. (MNKD) | 04-Feb-24 | Grant | 40,000 | $3.27 | $130,800.00 | 29% 136.15K to 176.15K | |
| 24-Jun-22 5:38 PM View: | Beigene, Ltd. (BGNE) | 22-Jun-22 | Grant | 16,692 | -- | -- | 214% 7.8K to 24.49K | |
| 01-Mar-22 5:00 PM View: | MannKind Corp. (MNKD) | 28-Feb-22 | Private Purchase | 40,000 | $2.71 | $108,400.00 | 13% 298.39K to 338.39K | |
| 21-Jun-21 4:38 PM View: | Beigene, Ltd. (BGNE) | 16-Jun-21 | Grant | 7,800 | -- | -- | 100% 0 to 7.8K | |
| 04-Mar-20 8:24 PM View: | MannKind Corp. (MNKD) | 04-Mar-20 | Grant | 30,048 | -- | -- | 31% 96.15K to 126.2K | |
| 07-May-18 7:01 PM View: | Amgen Inc. (AMGN) | 03-May-18 | Payment of Exercise | 883 | $169.43 | $149,607.00 | (< 1%) 216.03K to 215.15K | (34%) |
| 01-May-18 7:10 PM View: | Amgen Inc. (AMGN) | 27-Apr-18 | Grant | 4,508 | -- | -- | 2% 211.52K to 216.03K | |
| 27-Mar-18 7:42 PM View: | Amgen Inc. (AMGN) | 23-Mar-18 | Payment of Exercise | 8,807 | $176.08 | $1,550,740.00 | (4%) 220.33K to 211.52K | (29%) |
| 09-Mar-18 7:27 PM View: | Amgen Inc. (AMGN) | 07-Mar-18 | Grant | 17,638 | -- | -- | 9% 202.48K to 220.12K | |
| 01-Feb-18 8:38 PM View: | Amgen Inc. (AMGN) | 31-Jan-18 | Payment of Exercise | 651 | $191.27 | $124,517.00 | (< 1%) 203.13K to 202.48K | (18%) |
| 01-Feb-18 8:38 PM View: | Amgen Inc. (AMGN) | 30-Jan-18 | Payment of Exercise | 575 | $198.00 | $113,850.00 | (< 1%) 203.71K to 203.13K | (14%) |
| 03-May-17 8:50 PM View: | Amgen Inc. (AMGN) | 01-May-17 | Grant | 4,920 | -- | -- | 2% 198.48K to 203.4K | |
| 28-Mar-17 6:55 PM View: | Amgen Inc. (AMGN) | 24-Mar-17 | Payment of Exercise | 12,128 | $166.04 | $2,013,730.00 | (6%) 210.61K to 198.48K | (33%) |
| 09-Mar-17 5:08 PM View: | Amgen Inc. (AMGN) | 07-Mar-17 | Grant | 23,092 | -- | -- | 12% 187.31K to 210.4K | |
| 02-Feb-17 7:03 PM View: | Amgen Inc. (AMGN) | 31-Jan-17 | Payment of Exercise | 668 | $154.43 | $103,159.00 | (< 1%) 187.97K to 187.31K | (42%) |
| 31-Jan-17 7:10 PM View: | Amgen Inc. (AMGN) | 30-Jan-17 | Payment of Exercise | 598 | $157.16 | $93,981.70 | (< 1%) 188.57K to 187.97K | (40%) |
| 31-Jan-17 7:10 PM View: | Amgen Inc. (AMGN) | 28-Jan-17 | Payment of Exercise | 1,053 | $157.16 | $165,489.00 | (< 1%) 189.62K to 188.57K | (40%) |
| 05-May-16 8:30 PM View: | Amgen Inc. (AMGN) | 03-May-16 | Grant | 5,116 | -- | -- | 3% 184.2K to 189.31K | |
| 29-Apr-16 7:45 PM View: | Amgen Inc. (AMGN) | 27-Apr-16 | Payment of Exercise | 1,659 | $162.85 | $270,168.00 | (< 1%) 185.85K to 184.2K | (32%) |
| 29-Mar-16 5:13 PM View: | Amgen Inc. (AMGN) | 25-Mar-16 | Payment of Exercise | 23,785 | $149.24 | $3,549,670.00 | (11%) 209.64K to 185.85K | (44%) |
| 04-Mar-16 6:13 PM View: | Amgen Inc. (AMGN) | 02-Mar-16 | Grant | 45,268 | -- | -- | 28% 163.96K to 209.23K | |
| 01-Feb-16 8:30 PM View: | Amgen Inc. (AMGN) | 31-Jan-16 | Payment of Exercise | 651 | $152.73 | $99,427.20 | (< 1%) 164.61K to 163.96K | (40%) |
| 01-Feb-16 8:30 PM View: | Amgen Inc. (AMGN) | 28-Jan-16 | Payment of Exercise | 995 | $150.47 | $149,718.00 | (< 1%) 165.33K to 164.34K | (42%) |
| 28-Apr-15 7:56 PM View: | Amgen Inc. (AMGN) | 27-Apr-15 | Payment of Exercise | 1,575 | $167.91 | $264,458.00 | (< 1%) 166.91K to 165.33K | (25%) |
| 31-Mar-15 6:49 PM View: | Amgen Inc. (AMGN) | 27-Mar-15 | Payment of Exercise | 28,624 | $160.55 | $4,595,580.00 | (15%) 195.53K to 166.91K | (31%) |
| 13-Mar-15 6:32 PM View: | Amgen Inc. (AMGN) | 11-Mar-15 | Payment of Exercise | 27,540 | $153.58 | $4,229,590.00 | (12%) 222.69K to 195.15K | (37%) |
| 06-Mar-15 9:03 PM View: | Amgen Inc. (AMGN) | 04-Mar-15 | Grant | 107,354 | -- | -- | 93% 115.33K to 222.69K | |
| 03-Mar-15 8:52 PM View: | Amgen Inc. (AMGN) | 02-Mar-15 | Payment of Exercise | 3,215 | $157.72 | $507,070.00 | (3%) 118.55K to 115.33K | (34%) |
| 03-Feb-15 7:02 PM View: | Amgen Inc. (AMGN) | 30-Jan-15 | Grant | 4,597 | -- | -- | 4% 113.95K to 118.55K | |
| 30-Jan-15 4:58 PM View: | Amgen Inc. (AMGN) | 28-Jan-15 | Payment of Exercise | 959 | $158.89 | $152,376.00 | (< 1%) 114.91K to 113.95K | (32%) |
| 29-Apr-14 5:45 PM View: | Amgen Inc. (AMGN) | 27-Apr-14 | Payment of Exercise | 1,546 | $111.41 | $172,240.00 | (1%) 116.21K to 114.66K | (85%) |
| 14-Mar-14 4:11 PM View: | Amgen Inc. (AMGN) | 12-Mar-14 | Payment of Exercise | 27,540 | $124.27 | $3,422,400.00 | (19%) 143.75K to 116.21K | (66%) |
| 07-Mar-14 5:31 PM View: | Amgen Inc. (AMGN) | 05-Mar-14 | Grant | 52,777 | -- | -- | 58% 90.86K to 143.64K | |
| 04-Mar-14 4:31 PM View: | Amgen Inc. (AMGN) | 02-Mar-14 | Payment of Exercise | 7,537 | $124.02 | $934,739.00 | (8%) 98.4K to 90.86K | (67%) |
| 04-Feb-14 5:44 PM View: | Amgen Inc. (AMGN) | 31-Jan-14 | Grant | 5,044 | -- | -- | 5% 93.36K to 98.4K | |
| 14-Mar-13 6:20 PM View: | Amgen Inc. (AMGN) | 13-Mar-13 | Payment of Exercise | 27,540 | $91.75 | $2,526,800.00 | (23%) 120.6K to 93.06K | (121%) |
| 08-Mar-13 6:20 PM View: | Amgen Inc. (AMGN) | 06-Mar-13 | Grant | 52,777 | -- | -- | 78% 67.82K to 120.6K | |
| 04-Mar-13 6:28 PM View: | Amgen Inc. (AMGN) | 02-Mar-13 | Payment of Exercise | 6,998 | $92.58 | $647,875.00 | (9%) 74.82K to 67.82K | (119%) |
| 30-Jan-13 8:15 PM View: | Amgen Inc. (AMGN) | 28-Jan-13 | Grant | 7,477 | -- | -- | 11% 67.34K to 74.82K | |
| 01-May-12 8:55 PM View: | Amgen Inc. (AMGN) | 27-Apr-12 | Grant | 8,654 | -- | -- | 15% 58.57K to 67.23K | |
| 05-Mar-12 5:25 PM View: | Amgen Inc. (AMGN) | 02-Mar-12 | Payment of Exercise | 13,162 | $67.59 | $889,620.00 | (18%) 71.73K to 58.57K | (200%) |
| 02-Feb-12 8:08 PM View: | Amgen Inc. (AMGN) | 31-Jan-12 | Grant | 26,497 | -- | -- | 59% 45.24K to 71.73K | |
| 28-Oct-11 5:31 PM View: | Amgen Inc. (AMGN) | 27-Oct-11 | Grant | 45,238 | -- | -- | 100% 0 to 45.24K | |
| 17-May-11 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-May-11 | Payment of Exercise | 327,636 | $28.80 | $9,435,690.00 | (60%) 549.43K to 221.79K | (83%) |
| 17-May-11 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-May-11 | Option Exercise | 381,750 | $28.80 | $10,994,100.00 | 228% 167.68K to 549.43K | 83% |
| 17-May-11 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-May-11 | Market Option Sale | 13,372 | $28.80 | $385,104.00 | (6%) 221.79K to 208.42K | (83%) |
| 08-Mar-11 5:32 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Mar-11 | Payment of Exercise | 2,921 | $26.31 | $76,851.50 | (2%) 170.58K to 167.66K | (102%) |
| 08-Mar-11 5:32 PM View: | Bristol-Myers Squibb Co. (BMY) | 06-Mar-11 | Payment of Exercise | 4,041 | $26.43 | $106,804.00 | (2%) 174.62K to 170.58K | (101%) |
| 08-Mar-11 5:32 PM View: | Bristol-Myers Squibb Co. (BMY) | 06-Mar-11 | Option Exercise | 8,717 | -- | -- | 5% 165.9K to 174.62K | |
| 08-Mar-11 5:32 PM View: | Bristol-Myers Squibb Co. (BMY) | 04-Mar-11 | Payment of Exercise | 2,021 | $26.43 | $53,415.00 | (1%) 167.92K to 165.9K | (101%) |